Ania Jankowska

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

Fabı́ola Traina, Valeria Visconte, Paul Elson et al. · Leukemia · 2013 · 287 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy

Reda Z. Mahfouz, Ania Jankowska, Quteba Ebrahem et al. · Clinical Cancer Research · 2013 · 135 citations · Full text

Medicine, Molecular Biology, Pharmacology +10

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia

Sarah Abu Kar, Ania Jankowska, Hirokazu Makishima et al. · Haematologica · 2012 · 79 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysis

Jungwon Huh, Ramón V. Tiu, Lukasz P. Gondek et al. · Genes Chromosomes and Cancer · 2010 · 66 citations

Life Sciences, Genetics, Hematology +17

Donor–origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model

Aleksandra Klimczak, Şakir Ünal, Ania Jankowska et al. · Bone Marrow Transplantation · 2007 · 30 citations

Medicine, Cell Biology, Hematology +15